Skip to content

Clinical trials

Terminated Melanoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Status: Terminated Country / region: Australia Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20121
20134
20144
20155
20173
20182
20194
20203
20216
20222
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MacroGenics3
Novartis Pharmaceuticals3
Pfizer3
Amgen2
Array BioPharma2
Bristol-Myers Squibb2
Eli Lilly and Company2
GlaxoSmithKline2
Ludwig Institute for Cancer Research2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma42
Carcinoma, Non-Small-Cell Lung12
Neoplasms9
Squamous Cell Carcinoma of Head and Neck7
Colorectal Neoplasms5
Neoplasm Metastasis5
Head and Neck Neoplasms4
Pancreatic Neoplasms4
Skin Neoplasms4
Urinary Bladder Neoplasms4

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.